Antispasmodics in combination with analgesics.
Neospastil is a combination drug that belongs to the group of antispasmodics in combination with analgesics. It contains three active substances: the non-narcotic analgesic ketorolac tromethamine, the myotropic antispasmodic pitofenone hydrochloride and the cholinoblocking agent fenpiverinium bromide.
For short-term symptomatic treatment of moderate and severe pain syndrome:
with spasms of smooth muscles of internal organs: renal colic, spasms of the bladder and urinary tract, hepatic colic, spasms of the stomach and intestines, spastic dyskinesia of the biliary tract;
as an adjunct to relieve visceral pain after diagnostic procedures.
It is recommended for use in medical settings.
After intramuscular administration, the analgesic effect is observed in about 30 minutes, and the maximum pain control occurs in 1-2 hours. In general, the average duration of analgesia is 8-12 hours. The dose should be adjusted according to pain severity and the patient’s response to treatment. The likelihood of side effects can be minimized by using the lowest effective dose for the shortest period of time required to control symptoms. Epidural or intraspinal administration of the drug is contraindicated.
It is recommended that the ampoule of the medicine be warmed to body temperature before injection.